Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,745.5 11/10/16
52 week low1,363.0 24/06/16
52 week change 286.5 (20.58%)
4 week volume160,521,991 03/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 3911A GlaxoSmithKline PLC 23 March 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr K Slaoui b) Position/status PCA of Dr M M Slaoui (Chairman, Global Vaccines) c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allo...

Broker Forecast - Societe Generale issues a broker note on GlaxoSmithKline PLC

Societe Generale today reaffirms its sell investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price target at 1...

Director/PDMR Shareholding

RNS Number: 0892A GlaxoSmithKline PLC 21 March 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards As previously announced on 17 February 2017, Awards made to certain Executive Directors and Persons Discharging Managerial Responsibilities ('PDMR') made under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan ('DABP') on a pre...

GSK 2016 Form 20F

RNS Number: 8751Z GlaxoSmithKline PLC 17 March 2017 GlaxoSmithKline plc Annual Report 2016 on Form 20-F In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, GlaxoSmithKline plc ("GSK") announces that on 17 March 2017 it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that in...

Broker Forecast - Berenberg issues a broker note on GlaxoSmithKline PLC

Berenberg today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 18...

Director/PDMR Shareholding

RNS Number: 7375Z GlaxoSmithKline PLC 16 March 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr M M Slaoui b) Position/status Chairman, Global Vaccines c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market particip...

Director/PDMR Shareholding

RNS Number: 6058Z GlaxoSmithKline PLC 15 March 2017 GlaxoSmithKline plc (the ' Company ') Conditional Share Awards As previously announced, on 15 February 2017 the Company granted conditional awards to certain Executive Directors and Persons Discharging Managerial Responsibilities ('PDMR'). This announcement relates to a PDMR who elected to partic...

Publication of 2016 Annual Financial Report

RNS Number: 4280Z GlaxoSmithKline PLC 14 March 2017 GlaxoSmithKline plc Publication of 2016 Annual Report GlaxoSmithKline plc (the 'Company') will today publish on the Company's website, http://annualreport.gsk.com/ , its Annual Report for the year ended 31 December 2016 (the '2016 Annual Report'). A hard copy version of the 2016 Annual Report, together...

Fundamental DataMore

P/E ratio89.282
EPS18.8
Dividend yield4.766 %

Latest discussion posts More

  • Consumer sense or a sense of.....

    """Emma Walmsley is understood to have decided against a spin-off of Glaxosmithkline?s consumer healthcare division as she prepares to take formal charge of the pharmaceutical ...
    27-Mar-2017
    gamesinvestor
  • Re: Glaxo v Astra

    "What is holding GSK back and does anyone see this changing?" Dave, It's impossible to say really as the share prices seem to be driven by sentiment and hope, and dubiously ...
    25-Mar-2017
    gamesinvestor
  • Why the rise on Monday?

    The vote was withdrawn shortly after 15:30 US time. But its not all good for biotec....House Speaker Paul Ryan said this was "not the end of the story" ...
    24-Mar-2017
    Johandesilva

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
VODAFONE GRP.35%
BP34%
NATIONAL GRID32%
RDS 'B'31%
LLOYDS GRP.30%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK